Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas, SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers. The company was founded in 2012 and is based in Rockville, Maryland.
What is the ticker symbol for Shuttle Pharmaceuticals Holdings Inc? What does SHPH stand for in stocks?
SHPH is the stock ticker symbol of Shuttle Pharmaceuticals Holdings Inc. Every public company that trades on a stock exchange gets a ticker symbol.
What is the market capital of Shuttle Pharmaceuticals Holdings Inc (SHPH)?
As of Fri Dec 20 2024, market cap of Shuttle Pharmaceuticals Holdings Inc is 2.35 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.
What is the fair value of SHPH stock?
You can check SHPH's fair value in chart for subscribers.
Is Shuttle Pharmaceuticals Holdings Inc a good stock to buy?
The fair value guage provides a quick view whether SHPH is over valued or under valued. Whether Shuttle Pharmaceuticals Holdings Inc is cheap or expensive depends on the assumptions which impact Shuttle Pharmaceuticals Holdings Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SHPH.